Brandon Folkes

“Next up, we have a presentation from Collegium Pharmaceuticals, and joining us from Collegium is CEO Vikram Konani. Vikram, thanks very much for joining us.”

“You know, just following on from the earlier question, you talked about sort of the back-to-school wellness checks. So just sort of following on that theme, you know, as Zolt Suvmi continues to grow, can you just talk about pediatrician awareness of a product and the willingness of pediatricians to treat?”

“Can you just talk about the SG&A in the quarter and the updated guidance? You know, did you take any actions in the quarter, you know, whether it's – especially on the sales and marketing infrastructure, right, just on DefendCats or the existing Malenta portfolio?”

“Maybe just two from me. you know i guess firstly with the astrazeneca altamiris data released um you know are you having any updated conversations around c5 use at all obviously it's off-label right um but you know i guess any color in terms of wire transplant center would still use the c5 at all for these tATMA…”

“Maybe just two from me, staying on MROSI. You know, you look to be making very good progress here on the grocery net and obviously on volume.”